Properties (15)
Id 3547f14a-7b2b-4198-9ff8-0dbc0ede238c
Year 2025
Abstract
Cssclasses
- purpleRed
Aliases
- Prevalence of misophonia in patients with bipolar disorder
- (İletmiş & Yaman, 2025)
Import Date 01-25-2026
Template Version Notes •corrected error in rendering the linked PDF in metadata section • added the tag “noted” to the definition of comments to ignore ( like with the “in another note” tag. this is so that when making notes on chapters of a textbook, i can still export things for manual addition to the obsidian note without having to keep track of what has already been added ). Also moved the version notes to the yaml section • this version added the bookmarks section to auto collect all bookmarks. it also dropped the template auto fill of the initial source field because we never got it working and just overwrote it manually anyway. this version also added logic to handle “in another note” tag. annotations marked with this are completely ignored. used when i have information covered in a bigger note, but still want to highlight that part in text for visual clarity (so as to avoid duplicates of the same information) • running the import more then once will overwrite the file, so do not import again if you have made changes in obsidian that are not in the zotero article.
Dv Authors Gizem İletmiş, Gozde Bacik Yaman,
Dv Initial Source Misophonia MOC
Dv Status #status/Bare-bones-review
Dv Limitations • Cross-sectional design limits causal inference. • Single-site sample may limit generalizability. • Medication use not analyzed—possible confounder. • Hearing status based on self-report; objective testing recommended.
Dv Future Directions • Explore misophonia subtypes (pure vs. comorbid). • Clarify the role of pharmacology in symptom expression. • Use objective sensory testing and broader community sampling. • Further investigate emotion regulation components and hormonal influences (e.g., menstrual cycle).
Dv Relevance • study looking at the prevalence of Misophonia → Bipolar disorder (BD) comorbidity , the link between Misophonia and autistic traits and emotional regulation skills in BD. they found Misophonia to be more common in those without BD • they suggest that there may be subtypes of Misophonia that warrant further study (pure vs comorbid )
Checked For Zettle Notes true
Zotero Note Link Generated true
•
Prevalence of misophonia in patients with bipolar disorder: its relationship with autism spectrum symptoms and emotion regulation skills in comparison to a control group: Misophonia in bipolar disorder: autism and emotion regulation
Status:: #status/Bare-bones-review
Metadata
- Item Type: #journalArticle
- Authors:: Gizem İletmiş, Gozde Bacik Yaman,
- Date Added: August 20, 2025
- URL: https://www.tandfonline.com/doi/full/10.1080/08039488.2025.2511068
- DOI: 10.1080/08039488.2025.2511068
- Cite Key: iletmisPrevalenceMisophoniaPatients2025
- Tags:: #Autism, #Bare-bones-review-🦴, #clinical, #decreased-sound-tolerance-(DST), #Emotion, #Misophonia,
- PDF Attachments
Abstract
| Background/Purpose | Background- • Misophonia involves reduced tolerance to certain sounds and is linked to functional impairments and psychiatric comorbidities. • BD patients are known to exhibit sensory processing deficits and impaired auditory filtering, potentially predisposing them to misophonia. • Misophonia shares neurobiological features with autism spectrum disorder (ASD), especially in sensory sensitivity and insular cortex involvement. • Emotion regulation deficits are common in misophonia and BD and are associated with worse outcomes and increased psychopathology. Purpose- • Determine misophonia prevalence in bipolar disorder (BD) patients. • Assess the relationship between misophonia and autistic traits and emotion regulation skills in BD. • Compare results with a demographically matched healthy control group. • Hypotheses: Misophonia would be more prevalent in BD; misophonia severity would correlate with emotion dysregulation and autism traits. |
| Participants/samples | • 105 BD patients (DSM-5 diagnosis; in remission ≥3 months). • 105 matched healthy controls (age, gender, education). • Age range: 18–65 years. • Exclusion: other major psychiatric diagnoses, cognitive impairment, intellectual disability. |
| Measures | • Hamilton Depression Rating Scale (HDRS) – Depression severity. • Young Mania Rating Scale (YMRS) – Mania severity. • AMISOS-R – Misophonia symptoms. • ERSQ – Emotion regulation. • AQ – Autism spectrum traits. |
| Procedures | • Clinical interview for BD diagnosis and remission verification. • Self-report scales administered post-consent. • BD and control groups compared on scale scores and misophonia prevalence. • Regression analysis conducted to identify predictors of misophonia severity. |
| Results | • Prevalence: • Misophonia more common in controls (63.8%) than BD group (48.6%) (p=0.026). • BD patients with misophonia had higher AQ scores (p=0.003) and greater history of suicide attempts (p=0.026). • Severity: • Within BD: 29.4% subthreshold, 45.1% mild, 19.6% moderate, 5.9% severe misophonia. • AMISOS-R severity not significantly correlated with ERSQ or AQ scores in bivariate analysis. • Regression: • Suicide attempt history and AQ score significantly predicted misophonia severity. • Triggers and Reactions: • Chewing and breathing sounds were top triggers. • Discomfort and disgust were more common reactions in controls. • Gender/Hormonal Findings: • 7 of 16 reproductive-aged females reported worsened symptoms during menstruation. • Auditory Processing: • BD patients had more self-reported hearing difficulties than controls (p=0.020). |
| Discussion/Limits | Conclusion- • Contrary to hypotheses, misophonia was more prevalent in the control group. • In BD, misophonia was linked to higher autistic traits and suicide attempt history. • Emotion regulation skills were poorer in BD patients, particularly with high autistic traits. • Misophonia severity predicted by suicide attempt history and autism spectrum traits. • Misophonia may not be fully captured by current nosological frameworks; subtypes may exist. |
| Limitations:: | • Cross-sectional design limits causal inference. • Single-site sample may limit generalizability. • Medication use not analyzed—possible confounder. • Hearing status based on self-report; objective testing recommended. |
| Future Directions:: | • Explore misophonia subtypes (pure vs. comorbid). • Clarify the role of pharmacology in symptom expression. • Use objective sensory testing and broader community sampling. • Further investigate emotion regulation components and hormonal influences (e.g., menstrual cycle). |
| Relevance:: | • study looking at the prevalence of Misophonia → Bipolar disorder (BD) comorbidity , the link between Misophonia and autistic traits and emotional regulation skills in BD. they found Misophonia to be more common in those without BD • they suggest that there may be subtypes of Misophonia that warrant further study (pure vs comorbid ) |
Notes
key terms
-
Misophonia – A condition marked by intense negative emotional reactions (e.g., anger, disgust) to specific auditory stimuli such as chewing or breathing sounds. Not yet formally classified in diagnostic manuals.
-
Autism Spectrum Quotient (AQ) – A self-report scale assessing autistic traits across five domains: social skills, attention switching, attention to detail, communication, and imagination.
-
Emotion Regulation Skills Questionnaire (ERSQ) – A self-report scale measuring individuals' skills in regulating emotions.
-
Amsterdam Misophonia Scale-Revised (AMISOS-R) – A scale used to assess misophonia symptom severity and functional impairment, scored from 0 (none) to 40 (extreme).
-
Salience Network – A brain network (including the insular cortex) implicated in identifying and filtering relevant sensory stimuli; associated with misophonia and autism.